$64.23 -0.34 (-0.53%)
11/6/2009 4:01 PM

Novo Nordisk A/S (ADR) (NVO)

CAPS Rating: 5 out of 5

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals.

Current Price $64.23 Mkt Cap $40.72B
Open $63.93 P/E Ratio 26.25
Prev. Close $64.57 Div. (Yield) 0.78 (1.20%)
Daily Range $63.79 - $64.65 Volume 178,917
52-Wk Range $41.35 - $66.18 Avg. Daily Vol. 160,000

NVO News and Commentary

Caps

How do you think NVO will perform vs the S&P 500?

Add Stock to Watchlist

All Members

427 Outperform
11 Underperform
 

All-Star Members

132 Outperform
4 Underperform
 

Wall Street

6 Outperform
1 Underperform
 

Top NVO Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

indyjoneses (99.41)
Submitted May 28, 2009

Great play in a diabetes-focused pharamceutical company. As the general population ages, they will do better and better.

0 Comments | Reply | Report this Post

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NVO VS S&P 500 (SPY)

Fools bullish on NVO are also bullish on:

Fools bearish on NVO are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about NVO.

Recs

0
Member Avatar JChief (44.04) Submitted: 11/1/2009 1:13:34 AM : Outperform Start Price: $61.81 NVO Score: +0.30

Ran the numbers and feel good about it long term.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar mbhoch (< 20) Submitted: 10/14/2009 12:55:16 AM : Outperform Start Price: $64.17 NVO Score: +1.56

Novo has practically no debt whatsoever, over 20% profit margin and has good niche. They don't have a lot of competitors and they have an international reach with their products. They also pay a $0.74 dividend. The only thing I see as a problem is the high P/E ratio, they're trading well above their worth right now. So if you are a growth or value investor, this probably isn't a good buy right now, but a great stock for stability and income.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar wishlist3410 (44.50) Submitted: 10/13/2009 4:36:23 PM : Outperform Start Price: $64.17 NVO Score: +1.56

Diabetes is an every growing problem in our society. People still continue to eat what they want.

Report this Post 0 Comments | Reply | Permalink
View All 65 Pitches »

Leaderboard

Find the members with the highest scoring picks in NVO.

Score Leader

JaiVan

JaiVan (< 20) Score: +99.94

The Score Leader is the member with the highest score across all their picks in NVO.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
JaiVan < 20 8/28/2006 Outperform 5Y $34.16 +88.02% -11.92% +99.94
massoudb 94.73 9/20/2006 Outperform 3M $35.09 +83.04% -14.02% +97.06
carltahoe 63.48 9/26/2006 4/29/2008 Outperform 5Y $35.43 +81.31% -14.50% +95.81 1 Comment
johndyend 57.49 9/13/2006 Outperform 1Y $35.31 +81.92% -13.48% +95.41
TMFCherry 59.19 9/29/2006 Outperform 3Y $35.60 +80.43% -14.91% +95.34
Hcurb1 98.46 9/18/2006 Outperform 3Y $35.67 +80.04% -13.95% +94.00 1 Comment
TheHoldSteady 74.12 11/30/2006 Outperform 3M $36.96 +73.77% -19.02% +92.79
cmiscott 61.46 11/21/2006 Outperform 5Y $37.15 +72.90% -19.17% +92.06
Comatosis2007 < 20 10/18/2006 3/24/2008 Outperform 3Y $36.82 +74.45% -17.08% +91.52
Zenji 33.16 10/19/2006 Outperform 5Y $37.08 +73.23% -16.53% +89.76
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackJefferies 75.83 9/12/2009 Outperform NS $63.99 +0.38% +2.53% -2.15
TrackPiperJaff 80.38 5/12/2009 Outperform NS $50.41 +27.42% +19.35% +8.07
TrackCitigroup 21.22 4/24/2009 Outperform NS $48.31 +32.95% +25.83% +7.12
TrackUBS 86.41 3/26/2009 Outperform NS $51.00 +15.47% +22.48% -7.01 8/7/2009 @ $58.89
TrackCitigroup 21.22 1/14/2009 Underperform NS $50.07 -3.52% +0.47% +3.99 4/24/2009 @ $48.31
TrackJimCramer < 20 1/7/2009 Outperform 3W $53.02 +21.15% +20.24% +0.91
TrackDeutscheSec 89.50 10/6/2008 Outperform NS $50.91 +26.16% +2.58% +23.58
TrackJimCramer < 20 9/5/2008 Underperform 3W $51.71 +4.16% -27.13% -31.28 1/8/2009 @ $53.86
TrackBernstein 86.97 8/29/2008 Underperform NS $56.54 +13.60% -14.79% -28.39
TrackJimCramer < 20 7/31/2008 Outperform 3W $63.51 -18.58% -1.90% -16.68 9/6/2008 @ $51.71
TrackBernstein 86.97 2/8/2008 Outperform NS $60.30 -4.75% -1.42% -3.33 8/29/2008 @ $57.44
TrackBearStearns 86.38 1/23/2008 Outperform NS $57.82 +18.18% +7.91% +10.27 2/26/2008 @ $68.33
TrackEdwardOwens 98.26 9/30/2007 Outperform NS $58.80 +9.24% -26.44% +35.68 3 Comments
TrackJimCramer < 20 5/10/2007 Underperform 3W $50.81 +24.98% -15.21% -40.19 7/31/2008 @ $63.51
TrackJPMorgan 78.71 3/22/2007 Outperform NS $44.97 +22.80% +8.15% +14.66 7/16/2007 @ $55.22
TrackJimCramer < 20 3/21/2007 Outperform 3W $44.35 +16.07% +4.39% +11.69 5/11/2007 @ $51.49
TrackCitigroup 21.22 12/14/2006 Outperform NS $40.41 +29.55% +5.99% +23.55 5/3/2007 @ $52.35

Featured Broker Partners